Emma R. Parmee

3.0k total citations · 1 hit paper
36 papers, 1.8k citations indexed

About

Emma R. Parmee is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Organic Chemistry. According to data from OpenAlex, Emma R. Parmee has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Organic Chemistry. Recurrent topics in Emma R. Parmee's work include Diabetes Treatment and Management (14 papers), Receptor Mechanisms and Signaling (13 papers) and Peptidase Inhibition and Analysis (6 papers). Emma R. Parmee is often cited by papers focused on Diabetes Treatment and Management (14 papers), Receptor Mechanisms and Signaling (13 papers) and Peptidase Inhibition and Analysis (6 papers). Emma R. Parmee collaborates with scholars based in United States, United Kingdom and Germany. Emma R. Parmee's co-authors include R. M. Garbaccio, Orin Tempkin, Satoru Masamune, Matthew D. Truppo, Paul J. Coleman, Richard D. Tillyer, Spencer D. Dreher, Juan C. Alvarez, N.K. Terrett and Kevin R. Campos and has published in prestigious journals such as Science, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Emma R. Parmee

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The importance of synthetic chemistry in the pharmaceutical industry

2019 454 citations Kevin R. Campos, Paul J. Coleman et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma R. Parmee United States	21	1.0k	731	317	175	174	36	1.8k
William V. Murray United States	27	1.6k 1.5×	894 1.2×	131 0.4×	126 0.7×	188 1.1×	100	2.3k
Roger B. Ruggeri United States	24	1.1k 1.1×	815 1.1×	327 1.0×	61 0.3×	163 0.9×	43	2.2k
Toshimasa Tanaka Japan	27	992 1.0×	1.3k 1.7×	340 1.1×	190 1.1×	450 2.6×	59	2.6k
Frank Kayser United States	19	692 0.7×	725 1.0×	88 0.3×	140 0.8×	117 0.7×	33	1.4k
Gregory J. Wells United States	22	971 1.0×	697 1.0×	159 0.5×	99 0.6×	108 0.6×	54	1.9k
Gee‐Hong Kuo United States	22	540 0.5×	486 0.7×	134 0.4×	65 0.4×	52 0.3×	46	1.0k
Scott D. Edmondson United States	19	916 0.9×	716 1.0×	160 0.5×	164 0.9×	372 2.1×	40	1.7k
Ralph A. Rivero United States	22	852 0.8×	852 1.2×	63 0.2×	190 1.1×	82 0.5×	62	1.5k
Mario Cardozo United States	18	552 0.5×	773 1.1×	67 0.2×	76 0.4×	171 1.0×	31	1.4k
Johannes D. Aebi Switzerland	24	606 0.6×	1.1k 1.4×	64 0.2×	46 0.3×	93 0.5×	40	1.6k

Countries citing papers authored by Emma R. Parmee

Since Specialization

Citations

This map shows the geographic impact of Emma R. Parmee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma R. Parmee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma R. Parmee more than expected).

Fields of papers citing papers by Emma R. Parmee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma R. Parmee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma R. Parmee. The network helps show where Emma R. Parmee may publish in the future.

Co-authorship network of co-authors of Emma R. Parmee

This figure shows the co-authorship network connecting the top 25 collaborators of Emma R. Parmee. A scholar is included among the top collaborators of Emma R. Parmee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma R. Parmee. Emma R. Parmee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campos, Kevin R., Paul J. Coleman, Juan C. Alvarez, et al.. (2019). The importance of synthetic chemistry in the pharmaceutical industry. Science. 363(6424). 454 indexed citations breakdown →

Garbaccio, R. M. & Emma R. Parmee. (2016). The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective. Cell chemical biology. 23(1). 10–17. 57 indexed citations

Lin, Songnian, Fengqi Zhang, Guoqiang Jiang, et al.. (2015). A novel series of indazole-/indole-based glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 25(19). 4143–4147. 14 indexed citations

Mu, James, Guoqiang Jiang, E.J. Brady, et al.. (2011). Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice. Diabetologia. 54(9). 2381–2391. 59 indexed citations

Liang, Rui, Edward J. Brady, Mari R. Candelore, et al.. (2006). Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor. Bioorganic & Medicinal Chemistry Letters. 17(3). 587–592. 16 indexed citations

Cohen, Sheila M., Joseph Duffy, Corin O. Miller, et al.. (2005). Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor. Bioorganic & Medicinal Chemistry. 14(5). 1506–1517. 13 indexed citations

Helliwell, Madeleine, et al.. (2005). Total synthesis of milbemycins: a synthesis of (6R)-6-hydroxy-3,4-dihydromilbemycin E. Organic & Biomolecular Chemistry. 3(20). 3636–3636. 10 indexed citations

Varnerin, Jeffrey P., Caroline Chung, Sangita B. Patel, et al.. (2004). Expression, refolding, and purification of recombinant human phosphodiesterase 3B: definition of the N-terminus of the catalytic core. Protein Expression and Purification. 35(2). 225–236. 7 indexed citations

Dallas-Yang, Qing, Xiaolan Shen, Mathias Z. Strowski, et al.. (2004). Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists. European Journal of Pharmacology. 501(1-3). 225–234. 31 indexed citations

10.

Patel, Sangita B., Jeffrey P. Varnerin, Michael R. Tota, et al.. (2003). Crystallization and preliminary X-ray diffraction analysis of the catalytic domain of recombinant human phosphodiesterase 3B. Acta Crystallographica Section D Biological Crystallography. 60(1). 169–171. 2 indexed citations

11.

Edmondson, Scott D., Anthony Mastracchio, Jiafang He, et al.. (2003). Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(22). 3983–3987. 28 indexed citations

12.

Brockunier, Linda, Mari R. Candelore, Margaret A. Cascieri, et al.. (2001). Human β3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties. Bioorganic & Medicinal Chemistry Letters. 11(3). 379–382. 14 indexed citations

13.

Parmee, Emma R., Linda Brockunier, Jiafang He, et al.. (2000). Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 10(20). 2283–2286. 12 indexed citations

14.

Parmee, Emma R., Elizabeth M. Naylor, Vincent J. Colandrea, et al.. (1999). Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides. Bioorganic & Medicinal Chemistry Letters. 9(5). 749–754. 25 indexed citations

15.

Naylor, Elizabeth M., Emma R. Parmee, Vincent J. Colandrea, et al.. (1999). Human β3 andrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides. Bioorganic & Medicinal Chemistry Letters. 9(5). 755–758. 37 indexed citations

16.

Steel, Patrick G., O. S. Mills, Emma R. Parmee, & Eric J. Thomas. (1997). Total synthesis of milbemycin E: resolution of the C(1)–C(10) fragment and final assembly. Journal of the Chemical Society Perkin Transactions 1. 391–400. 9 indexed citations

17.

Parmee, Emma R., Yaping Hong, Orin Tempkin, & Satoru Masamune. (1992). The catalytic asymmetric aldol reaction of aldehydes with unsubstituted and monosubstituted silyl ketene acetals: formation of anti-β-hydroxy-α-methyl esters. Tetrahedron Letters. 33(13). 1729–1732. 74 indexed citations

18.

Parmee, Emma R., Orin Tempkin, Satoru Masamune, & Atsushi Abiko. (1991). New catalysts for the asymmetric aldol reaction: chiral boranes prepared from .alpha.,.alpha.-disubstituted glycine arenesulfonamides. Journal of the American Chemical Society. 113(24). 9365–9366. 143 indexed citations

19.

Parmee, Emma R., et al.. (1991). Milbemycin synthesis: synthesis of 6β-hydroxy-3,4-dihydromilbemycin E. Tetrahedron Letters. 32(20). 2269–2272. 13 indexed citations

20.

Parmee, Emma R., Patrick G. Steel, & Eric J. Thomas. (1989). A total synthesis of milbemycin E. Journal of the Chemical Society Chemical Communications. 1250–1250. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact